Sorry!! The article you are trying to read is not available now.
BioTech/Pharma
Log In
Bussiness News
Politics And Regulation
Markets
The Economy
Editor's Pick
Trading And Investing
Stocks
ETFs
Fixed Income
Currencies
Earnings
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Hoofy & Boo
Radio
From The Buzz & Banter
Daily Recap
MV Education center
Video
t3 live subscriptions
Buzz And Banter
Cooper's Market Report
Techstrat Report
The Options Strategist
Minyanville
All Biotech/pharma Articles
Get
FREE MINYANVILLE
Newsletters & Alerts
Generic Drugs as Market Disruptors: Why CVS, Perrigo Will Benefit
By
Chat Reynders
Apr 28, 2014 1:53 pm
The market players who are positioned to lead a new surge in generic drug sales are making huge strides.
Read this article
Conference Call Takeaways: AbbVie Stock Has Little Upside; Ford Set to Outperform Into 2015
Tom Clancy
Allergan Case Study: Take Profits After Getting Lucky in a Stock
Brandon Perry
Is a Correction in the Charts for Health Care Stocks?
Howard Simons
Biotech Stocks to Watch as Sector Sells Off
Kapitall
Why Gilead's Hepatitis C Vaccine Is So Hard to Value
Tom Clancy
Recommendations
Archive
March, 2018
February, 2018
January, 2018
December, 2017
November, 2017
October, 2017
September, 2017
August, 2017
July, 2017
June, 2017
May, 2017
April, 2017
TICKERS
PFE
MRK
JNJ
BMY
GSK
DNDN
GILD
VRTX
AMGN
LLY
ARNA
BIIB
See All Tickers »